Oliver Cornely to Invasive Pulmonary Aspergillosis
This is a "connection" page, showing publications Oliver Cornely has written about Invasive Pulmonary Aspergillosis.
Connection Strength
2.169
-
Diagnostic dilemma in COVID-19-associated pulmonary aspergillosis - Authors' reply. Lancet Infect Dis. 2021 06; 21(6):767-769.
Score: 0.518
-
Baseline predictors influencing the prognosis of invasive aspergillosis in adults. Mycoses. 2019 Aug; 62(8):651-658.
Score: 0.458
-
EQUAL Aspergillosis Score 2018: An ECMM score derived from current guidelines to measure QUALity of the clinical management of invasive pulmonary aspergillosis. Mycoses. 2018 Nov; 61(11):833-836.
Score: 0.431
-
Intensive care medicine research agenda on invasive fungal infection in critically ill patients. Intensive Care Med. 2017 Sep; 43(9):1225-1238.
Score: 0.392
-
Taskforce report on the diagnosis and clinical management of COVID-19 associated pulmonary aspergillosis. Intensive Care Med. 2021 08; 47(8):819-834.
Score: 0.132
-
Isavuconazole treatment for rare fungal diseases and for invasive aspergillosis in patients with renal impairment: Challenges and lessons of the VITAL trial. Mycoses. 2018 Jul; 61(7):420-429.
Score: 0.106
-
Impact of unresolved neutropenia in patients with neutropenia and invasive aspergillosis: a post hoc analysis of the SECURE trial. J Antimicrob Chemother. 2018 03 01; 73(3):757-763.
Score: 0.105
-
A Comparison of Aspergillus and Mucorales PCR Testing of Different Bronchoalveolar Lavage Fluid Fractions from Patients with Suspected Invasive Pulmonary Fungal Disease. J Clin Microbiol. 2018 02; 56(2).
Score: 0.026